Total amount raised
$98 Millions
Latest funding date
03/01/2022
Location
Deepcell has successfully raised $73 million to advance its single-cell imaging technology, leveraging AI and microfluidics for detailed cell analysis. The company has attracted a total of 11 investors, including Fifty Years and Bow Capital, through various funding rounds.
Keep reading to explore the intricacies of Deepcell's fundraising journey and the investors backing this innovative platform.
What Is Deepcell?
Deepcell, founded on July 10, 2017, is a biotechnology company based in Menlo Park, California. The company specializes in AI-powered single-cell classification and isolation for basic and translational research.
Founded by Euan Ashley, Maddison Mahdokht Masaeli, and Mahyar Salek, Deepcell employs between 101-250 people. The company leverages advanced technologies like microfluidics, optics, and AI to provide high-dimensional quantitative readouts of single-cell morphology.
How Much Funding Has Deepcell Raised?
- Seed Round
- Amount Raised: $5M
- Date: December 2017
- Lead Investors: Andreessen Horowitz
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support the initial development and commercialization of Deepcell's AI-powered single-cell analysis technology.
- Series A
- Amount Raised: $20M
- Date: December 2020
- Lead Investors: Bow Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop the platform and prepare for early commercial introduction.
- Series B
- Amount Raised: $73M
- Date: March 2022
- Lead Investors: Koch Disruptive Technologies
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate the scaling of operations, develop the platform further, and enable early commercial introduction.
Total Amount Raised: $98M. Current Valuation: Not publicly disclosed.
Key Investors
- Koch Disruptive Technologies
- Details: Koch Disruptive Technologies (KDT) is a subsidiary of Koch Industries focused on investing in high-growth companies that are innovating and transforming industries.
- Investment Focus Areas: Artificial Intelligence, Biotechnology, Health Care, Life Sciences
- Notable Investments: Desktop Metal, InSightec
- Bow Capital
- Details: Bow Capital is a venture capital firm that invests in transformative technology companies.
- Investment Focus Areas: Artificial Intelligence, Biotechnology, Health Care, Life Sciences
- Notable Investments: Not publicly disclosed
- Andreessen Horowitz
- Details: Andreessen Horowitz is a private venture capital firm that invests in both early-stage start-ups and established growth companies.
- Investment Focus Areas: Artificial Intelligence, Biotechnology, Health Care, Life Sciences
- Notable Investments: Facebook, Airbnb, Lyft
- Horizons Ventures
- Details: Horizons Ventures is a venture capital firm known for investing in disruptive and technology-driven companies.
- Investment Focus Areas: Technology, Innovation
- Notable Investments: Facebook, Spotify, Zoom
- Casdin Capital
- Details: Casdin Capital is an investment firm focused on life sciences and healthcare.
- Investment Focus Areas: Life Sciences, Healthcare
- Notable Investments: 10x Genomics, Relay Therapeutics
What's Next for Deepcell?
Deepcell stands on the brink of significant growth, with its "morpholomics" platform poised to revolutionize single-cell analysis. The company is set to scale operations and introduce its technology to a growing market, offering unprecedented biological insights that could transform precision medicine and translational research.
Future fundraising opportunities appear promising as Deepcell transitions to late-stage development and commercialization. The company may attract further investment to support full-scale market entry and expansion, potentially forming strategic partnerships with other biotech firms.
However, challenges lie ahead. Deepcell must navigate the complexities of commercialization, ensure the scalability and reliability of its technology, and compete with other emerging players in the single-cell analysis space. Regulatory hurdles and maintaining cell integrity during analysis will also be critical factors in their journey forward.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Deepcell and gather other critical business insights.
Sign up for free to start transforming your sales strategy today.
